WASHINGTON — Two prominent Democratic lawmakers are requesting that the Federal Trade Commission investigate whether price hikes for two blockbuster blood thinners were illegally coordinated by Janssen and Bristol Myers Squibb.
Sen. Amy Klobuchar (D-Minn.), the chair of the Senate Judiciary Committee’s subcommittee on antitrust enforcement, and Rep. Katie Porter (D-Calif.), a rising star in the Democratic Party and a member of the House’s oversight panel, wrote to the FTC on Monday regarding what they called “parallel” price hikes on Xarelto and Eliquis, drugs that patients take to prevent heart attacks, strokes, and blood clots.
Click this link for the original source of this article.
Author: Rachel Cohrs
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.